HIV PrEP as an Entry Point to the Elimination of Hepatitis B Virus

In 2022, the Global Fund to Fight AIDS, Tuberculosis and Malaria made a welcome move to enable increased financial support for viral hepatitis. International organisations and patient groups have called on countries to include viral hepatitis prevention and treatment services in their national proposals to the Global Fund, and also called on funders such as the US President’s Emergency Plan for AIDS Relief (PEPFAR) to integrate viral hepatitis into their programmes.

The Global Fund, in its modular framework for the 2023–25 funding allocation period, have identified interventions where national proposals can include key population-related services relevant to hepatitis B. The framework also identifies HIV pre-exposure prophylaxis (PrEP) and hepatitis B prevention, vaccination, screening, care, and treatment as a part of the public health intervention packages for all people in key populations (such as people who use drugs, men who have sex with men, sex workers, and transgender people).

Access the full correspondence, published in The Lancet Gastroenterology & Hepatology, here.
/free registration is required/